Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Oestrogen deficiency | Phase 2 | US | - |
Phase 1 | 12 | (Post Menopausal Women Without Diabetes) | kzixjgwryv(oxaqdgmypo) = zyyvhwxgxl yrjyewlptg (gjelgexbkv, satunayqly - biretjtsvx) View more | - | 27 Sep 2022 | ||
(Post Menopausal Women With Diabetes) | kzixjgwryv(oxaqdgmypo) = cnjfwwxbdz yrjyewlptg (gjelgexbkv, qnonlqvtjn - bkndzsmzut) View more |